Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
10
Frequently Asked Questions
What is Market Cap of Tvardi Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tvardi Therapeutics Inc. market cap is $291.73M.
What is the 52-week high for Tvardi Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tvardi Therapeutics Inc. 52 week high is $34.31 as of September 07, 2025.
What is the 52-week low for Tvardi Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tvardi Therapeutics Inc. 52 week low is $8.13 as of September 07, 2025.
What is Tvardi Therapeutics Inc. stock price today?
Tvardi Therapeutics Inc. stock price today is $31.11.
What was Tvardi Therapeutics Inc. stock price yesterday?
Tvardi Therapeutics Inc. stock price yesterday was $30.44.
What is the PE ratio of Tvardi Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Tvardi Therapeutics Inc.’s P/E ratio is -1.78.
What is the Price-to-Book ratio of Tvardi Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Tvardi Therapeutics Inc. P/B ratio is 8.8562.
What is the 50-day moving average of Tvardi Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tvardi Therapeutics Inc. 50-day moving average is $25.74.
How many employess does Tvardi Therapeutics Inc. has?
